Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ng decrease » a decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
50 ng » 50 mg (Expand Search), 10 ng (Expand Search), 5 ng (Expand Search)
Showing 1 - 20 results of 21,196 for search '(( 50 ng decrease ) OR ((( 50 ((nn decrease) OR (_ decrease)) ) OR ( 5 fold decrease ))))', query time: 0.40s Refine Results
  1. 1
    Detection of the Challenging mutations at 1% VAF and 50 ng DNA input.

    Detection of the Challenging mutations at 1% VAF and 50 ng DNA input. by Lizhi Yu (12476136)

    Published 2022
    Save to List
    Saved in:
  2. 2
    IC<sub>50</sub>s data of antimalarials against controls.

    IC<sub>50</sub>s data of antimalarials against controls. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 3
    Drugs IC<sub>50</sub>s data during the study period.

    Drugs IC<sub>50</sub>s data during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 4
    SNPs IC<sub>50</sub>s data at codon 876 during the study period.

    SNPs IC<sub>50</sub>s data at codon 876 during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 5
    Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone.

    Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. by O’Llenecia S. Walker (8486163)

    Published 2020
    Save to List
    Saved in:
  6. 6
    Association of polymorphic IC<sub>50s</sub> versus wild<i>-</i>type at codon 876 in selected drugs tested.

    Association of polymorphic IC<sub>50s</sub> versus wild<i>-</i>type at codon 876 in selected drugs tested. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 7
    Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs.

    Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. by Yang Zhang (30734)

    Published 2024
    Save to List
    Saved in:
  8. 8
    ROC curve and P-R curve (attack traffic proportion = 50%).

    ROC curve and P-R curve (attack traffic proportion = 50%). by Longyan Ran (18452261)

    Published 2024
    Save to List
    Saved in:
  9. 9
    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 10
    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 11
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Assessment of cell proliferation within the vocal fold muscle following DFATs transplantation.

    Assessment of cell proliferation within the vocal fold muscle following DFATs transplantation. by Ikuo Mikoshiba (9312007)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Distribution of miRs with a greater than two fold-change.

    Distribution of miRs with a greater than two fold-change. by Stephanie L. Samani (17896610)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 17
    Flow chart of the study procedures.

    Flow chart of the study procedures. by Kazuhiko Ikeuchi (9234268)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 18
    Fold change with steady state myocardial mRNA levels for components of the inflammasome.

    Fold change with steady state myocardial mRNA levels for components of the inflammasome. by Stephanie L. Samani (17896610)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 19
    Number of samples per site during the study period.

    Number of samples per site during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 20
    Performance of selected antimalarials against field isolates during the study period.

    Performance of selected antimalarials against field isolates during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: